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Abstract: A prospective analysis of women with terminal breast cancer admitted to CHNE from November 2006-August 
2007 evaluated anecdotal observations that African American (AA) women are likelier than Caucasian women to evidence 
loco-regional recurrences (LRR). Women with terminal breast cancer who were admitted to CHNE, a not-for-proﬁ  t hospice 
serving over 90% of Northeast Florida hospice patients, were eligible for participation. 134 terminal breast cancer patients 
were assessed by hospice nurses for LRR presence via chest wall examination. 80% of them (107) were Caucasian, 17% 
(23) were AA and 3% (4) were of other ethnicities. Evidence of LRR were noted in 13% of the women (17/134). The pro-
portion of patients with LRR was higher in AA women than Caucasian women (26% vs. 10%, 6/23 vs. 11/107, respectively), 
although this difference was not statistically signiﬁ  cant (p = 0.08). The majority of Caucasian women with LRR consented 
to a medical record review, but a minority of AA women consented (8/11 vs. 2/6, respectively, p = 0.16).
Conclusion: Evaluating disparities in breast cancer care outcomes is possible by reviewing data from patients served by 
hospice programs that aid a majority of patients within a community. This pilot data suggests that AA women with breast 
cancer have a higher incidence of loco-regional failure as a component of their terminal breast cancer disease than Cauca-
sian women. A smaller proportion of AA patients and families agreed to participate in a medical record review study than 
Caucasians. Larger studies are necessary to conﬁ  rm these ﬁ  ndings, to elucidate factors contributing to disparities and to 
develop potential solutions.
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Introduction
CHNE is a not-for-proﬁ  t hospice that serves over 90% of hospice patients in Northeast Florida, which 
includes Duval, Nassau, St. Johns, and Putnam counties. The enrollment of a majority of hospice patients 
in a given community by a single, not-for proﬁ  t program facilitates the conduct of community-based 
studies of terminal cancer patients that may show evidence of disparities in cancer care. Unfortunately, 
disparities research involving hospice patients has not been frequently reported. A Pub Med search 
conducted October, 2008, of “hospice and disparities” yielded only 26 articles published since 1989 in 
the English-language literature.
Anecdotal observations of terminal breast cancer patients cared for at CHNE suggested that, upon 
enrollment to hospice, African American (AA) patients were more likely to have evidence of loco-
regional recurrence (LRR) as part of the extent of their disease than Caucasian patients. Multiple factors 
have been associated with a higher incidence of LRR among breast cancer patients including younger 
age, tumor size, tumor grade, hormone receptor status, her-2 status, lymph node involvement, presence 
of positive surgical margins and presence of lymphovascular space invasion.
1–4 Compared to Caucasian 
women with breast cancer, AA women are less likely to receive adjuvant treatments for their breast 
cancer, which puts them at a higher risk for LRR.
5 In part, these disparities are secondary to a higher 
incidence of co-morbidities and a higher incidence of lack of insurance in AA women.
5 Pierce et al. 
reported that AAs had a higher incidence of regional failure as part of the ﬁ  rst site of failure than Cau-
casians (16% vs. 4%).
1 Fowble et al. reported that women diagnosed at ages younger than 35 years old 
had a 24% risk of LRR; this was signiﬁ  cantly higher than that of older women.
2 AA women are more 548
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likely to develop breast cancer at a younger age 
than Caucasian women.
6 Triple negative (estrogen 
receptor, progesterone receptor, and her-2-neu 
negative) breast cancers typically have a more 
aggressive behavior with poorer prognosis than 
other breast cancers and are more common in 
younger AA women than older AA women.
3
We sought to provide further evidence that 
supports anecdotal observations of a higher 
incidence of loco-regional failure as part of the 
terminal disease manifestations of AA patients 
entering CHNE hospice programs. If data sup-
porting these observations was obtained, we 
planned to follow up this prospective pilot study 
with a more detailed analysis involving a larger 
cohort of patients.
Methods
A Mayo Clinic, IRB-approved prospective study 
of breast cancer patients enrolled in CHNE was 
performed from December 2006 to August 2007. 
The study investigated LRR incidence as part of 
terminal-stage breast cancer manifestation to deter-
mine if it was higher in AA or Caucasian patients. 
A patient was classiﬁ  ed as having terminal-stage 
breast cancer if the patient had metastatic breast 
cancer and was enrolled in hospice and did not 
receive additional chemotherapy or radiation treat-
ments. Hospice nurses evaluated the patients for 
the presence of LRR upon enrollment to CHNE by 
performing a physical examination of the chest 
wall. Nurses also asked patients or the patients’ 
relatives for consent to obtain medical records for 
review and for patients or their relatives to meet 
with a Mayo Clinic research coordinator for an 
interview. An in-depth review of the medical 
records of 10 consenting patients with LRR was 
performed. This pilot study was designed with the 
intent of accruing 10 patients who would consent 
to a medical record review; sample size was not 
based on any power calculations. Fisher’s exact 
test was used to compare proportions of patients 
with LRR between groups as well as proportions 
consenting to a medical record review.
Results
A total of 134 consecutive women with termi-
nal stage breast cancer who were enrolled in 
CHNE from December 2006 to August 2007 
were evaluated. 80% (107 patients) were Caucasian, 
17% (23 patients) were AA, and 3% (4 patients) 
were of other ethnicities. This distribution of 
ethnicities is similar to that of the general 
population of Northeast Florida, though the 
percentage of AAs in Northeast Florida is some-
what higher and estimated at 27%. Evidence of 
LRR was noted in 13% of the women (17/134 
patients). The incidence of LRR was higher in AA 
women than Caucasian women (26% vs. 10%, 
6/23 vs. 11/107, respectively, p = 0.08). The 
majority of Caucasian women with LRR consented 
to a review of their medical records, but a minority 
of the AA women consented (8/11 vs. 2/6 patients 
respectively, p = 0.16).
We undertook an extensive medical record 
review of the 2 AA and 8 Caucasian patients who 
consented and interviewed patients or their imme-
diate relatives to ascertain which of the described 
risk factors for LRR were present. Delays in initial 
diagnosis due to lack of insurance, patient’s denial 
of breast cancer diagnosis, the presence of locally 
advanced breast cancer at diagnosis, and late 
relapses (5 years) of breast cancer were noted as 
potentially contributing factors in these 10 cases 
(Table 1).
Discussion
This exploratory pilot study suggests that AA 
patients with terminal breast cancer may be more 
likely than Caucasian patients to have evidence 
of LRR, which supports the impression of anec-
dotal observations. A medical record review of 
10 patients with LRR suggests that common, 
potential factors contributing to LRR in the patient 
population we reviewed are delays in diagnosis 
due to lack of insurance and fear of breast cancer 
diagnosis. Locally advanced breast cancer was 
present at initial diagnosis in 3 of the cases and this 
likely contributed to LRR development. Interest-
ingly, 4 patients experienced late (5 years) LRR; 
these results stress the importance of ongoing 
surveillance in the care of breast cancer survivors. 
Many cancer survivors consider their cancer cured 
if no relapse occurs in ﬁ  ve years. It is conceivable 
that both patients and their care providers were not 
as vigilant of LRR after 5 years. Three of the 
patients with LRR whose medical records were 
reviewed were diagnosed more than 10 years after 
the original diagnosis of breast cancer.
The availability of a not-for proﬁ  t, community-
based hospice program that serves a majority of 
patients from one region makes it feasible to 
analyze these patients and determine the possible 549
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presence of disparities in outcome as demonstrated 
by our study. A partnership between cancer centers 
and hospice programs can lead to research studies 
that will eliminate disparities and improve the 
palliative care of terminal-stage cancer patients.
The results also suggest that AA families may 
be less willing to consent to study participation 
than Caucasian families. Obtaining consents for 
research studies during the terminal stages of 
cancer is difﬁ  cult given how stressful this clinical 
situation is for patients and their families. Patients 
may be sedated and unable to provide consent and 
families may not be certain about the wishes of 
patients or be comfortable acting as surrogates for 
consent. The number of patients evaluated in our 
study was too small to reach any deﬁ  nite conclusions 
and further studies are warranted to follow-up on 
our ﬁ  ndings.
There are several limitations to this study. 
Sample sizes were small and no power calculations 
were part of the original design of this pilot study. 
The study was conceived as a hypothesis-generating 
pilot study with the understanding that a larger, 
prospective study will be needed to conﬁ  rm the 
signiﬁ  cance of the pilot observations. Such a study 
is currently underway. Even though CHNE pro-
vides hospice care to 90% of the Northeast Florida 
population it is possible that different qualitative 
results would result from a study including patients 
served by other hospice providers. Characteristics 
of women with terminal breast cancer who are not 
enrolled in hospice may also differ from those in 
hospice, and differential proportions of AA and 
Caucasian women may be enrolled in hospice. 
These possibilities limit our ability to generalize 
these ﬁ  ndings to the breast cancer population of 
Northeast Florida. In addition, patients with LRR 
were examined and results were documented by 
nurses; conﬁ  rmation by radiographic studies or 
medical examinations were not undertaken, thus 
the validity of the data may be limited.
Signiﬁ  cant morbidity can be associated with 
LRR. Several patients developed painful ulcerated 
lesions and associated infections. It is important 
that palliative management of patients with meta-
static disease include efforts to minimize the risk 
of LRR even in the presence of disseminated 
disease. This is particularly important given the 
increasing median survival of patients with 
metastatic breast cancer.
Conclusions
Evaluation of disparities in outcomes of breast 
cancer care in a given region is facilitated with the 
existence of a hospice program that serves the 
majority of the patients within that community. AA 
women with breast cancer seem to have a higher 
incidence of loco-regional failure as a component 
of their terminal breast cancer disease than Cau-
casian women. A smaller proportion of AA patients 
and families agreed to participate in a medical 
record review study than Caucasian patients and 
families.
Multiple factors likely contribute to LRR in the 
patients studied, including lack of insurance, which 
delays diagnosis, and a lack of awareness about 
the beneﬁ  ts of timely breast cancer management. 
Programs that improve the education of this popu-
lation about the importance of early diagnosis and 
programs that improve access to care of the general 
population are likely to ameliorate the problems. 
Further studies with a larger cohort of patients are 
indicated in order to conﬁ  rm these ﬁ  ndings as well 
as to hopefully elucidate the main factors contrib-
uting to disparities and help formulate potential 
solutions.
Acknowledgment
Funded in part by the Mayo Clinic Comprehensive 
Cancer Center grant (NCI grant number P50-
CA01508).
Table 1. Potential contributing factors to LRR identiﬁ  ed in studied patients (n = 10).
Potential contributing factor* Caucasian (n = 8) AA (n = 2)
Lack of insurance causes diagnosis delay. 4 0
Late relapses (5 years) after original diagnosis. 31
Patient’s denial of breast cancer diagnosis. 4 0
Locally advanced breast cancer at presentation. 3 0
*More than one factor was noted in several patients.550
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